» Articles » PMID: 36451852

Clearance Pathways of Near-infrared-II Contrast Agents

Overview
Journal Theranostics
Date 2022 Dec 1
PMID 36451852
Authors
Affiliations
Soon will be listed here.
Abstract

Near-infrared-II (NIR-II) bioimaging gradually becomes a vital visualization modality in the real-time investigation for fundamental biological research and clinical applications. The favorable NIR-II contrast agents are vital in NIR-II imaging technology for clinical translation, which demands good optical properties and biocompatibility. Nevertheless, most NIR-II contrast agents cannot be applied to clinical translation due to the acute or chronic toxicity caused by organ retention imaging. Therefore, it is critical to understand the pharmacokinetic properties and optimize the clearance pathways of NIR-II contrast agents to minimize toxicity by decreasing organ retention. In this review, the clearance mechanisms of biomaterials, including renal clearance, hepatobiliary clearance, and mononuclear phagocytic system (MPS) clearance, are synthetically discussed. The clearance pathways of NIR-II contrast agents (classified as inorganic, organic, and other complex materials) are highlighted. Successively analyzing each contrast agent barrier, this review guides further development of the clearable and biocompatible NIR-II contrast agents.

Citing Articles

Recent Progress in Molecular Probes for Imaging of Acute Kidney Injury.

Sitara M, Zhang W, Gao H, Li J, Tian J Chem Biomed Imaging. 2024; 2(8):526-541.

PMID: 39473990 PMC: 11503706. DOI: 10.1021/cbmi.4c00024.


Trisulfide Bond-Mediated Molecular Phototheranostic Platform for "Activatable" NIR-II Imaging-Guided Enhanced Gas/Chemo-Hypothermal Photothermal Therapy.

Wu G, Liu F, Li N, Fu Q, Wang C, Yang S Adv Sci (Weinh). 2023; 10(36):e2304104.

PMID: 37983599 PMC: 10754146. DOI: 10.1002/advs.202304104.


Assessment of Inner Blood-Retinal Barrier: Animal Models and Methods.

Bora K, Kushwah N, Maurya M, Pavlovich M, Wang Z, Chen J Cells. 2023; 12(20).

PMID: 37887287 PMC: 10605292. DOI: 10.3390/cells12202443.


NIR-II Nanoprobes: A Review of Components-Based Approaches to Next-Generation Bioimaging Probes.

Dunn B, Hanafi M, Hummel J, Cressman J, Veneziano R, Chitnis P Bioengineering (Basel). 2023; 10(8).

PMID: 37627839 PMC: 10451329. DOI: 10.3390/bioengineering10080954.

References
1.
Li Y, Bai G, Zeng S, Hao J . Theranostic Carbon Dots with Innovative NIR-II Emission for in Vivo Renal-Excreted Optical Imaging and Photothermal Therapy. ACS Appl Mater Interfaces. 2019; 11(5):4737-4744. DOI: 10.1021/acsami.8b14877. View

2.
Dang Y, Lai Y, Chen F, Sun Q, Ding C, Zhang W . Activatable NIR-II Fluorescent Nanoprobe for Rapid Detection and Imaging of Methylglyoxal Facilitated by the Local Nonpolar Microenvironment. Anal Chem. 2022; 94(2):1076-1084. DOI: 10.1021/acs.analchem.1c04076. View

3.
Mills J, Liu F, Jarrett T, Fletcher N, Thurecht K . Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation. Biomater Sci. 2022; 10(12):3029-3053. DOI: 10.1039/d2bm00181k. View

4.
Dong Z, Cui H, Wang Y, Wang C, Li Y, Wang C . Biocompatible AIE material from natural resources: Chitosan and its multifunctional applications. Carbohydr Polym. 2019; 227:115338. DOI: 10.1016/j.carbpol.2019.115338. View

5.
Liu L, Wang S, Zhao B, Pei P, Fan Y, Li X . Er Sensitized 1530 nm to 1180 nm Second Near-Infrared Window Upconversion Nanocrystals for In Vivo Biosensing. Angew Chem Int Ed Engl. 2018; 57(25):7518-7522. DOI: 10.1002/anie.201802889. View